{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:39:05Z","timestamp":1792017545826,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012899","name":"Lanzhou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012899","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bmc.2024.117752","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T07:23:06Z","timestamp":1715239386000},"page":"117752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Discovery of indole-2-one derivatives as BRD4 (BD1) selective inhibitors"],"prefix":"10.1016","volume":"106","author":[{"given":"Xue-Peng","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Xia","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Shan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Wu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.117752_b0005","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3109\/15376516.2011.559695","article-title":"From Waddington\u2019s epigenetic landscape to small noncoding RNA: some important milestones in the history of epigenetics research","volume":"21","author":"Choudhuri","year":"2011","journal-title":"Toxicol Mech Methods"},{"key":"10.1016\/j.bmc.2024.117752_b0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1126\/science.3310230","article-title":"The inheritance of epigenetic defects","volume":"238","author":"Holliday","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.bmc.2024.117752_b0015","doi-asserted-by":"crossref","first-page":"9390","DOI":"10.1074\/jbc.M109.057745","article-title":"cAMP-response element-binding protein (CREB) controls MSK1-mediated phosphorylation of histone H3 at the c-fos promoter in vitro","volume":"285","author":"Shimada","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.117752_b0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejcb.2014.03.001","article-title":"Role of histone acetyltransferases and histone deacetylases in adipocyte differentiation and adipogenesis","volume":"93","author":"Zhou","year":"2014","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.bmc.2024.117752_b0025","first-page":"344","article-title":"Role of histone acetylation in the control of gene expression, Biochem. Cell Biol. Biochim","volume":"83","author":"Verdone","year":"2005","journal-title":"Biol Cell"},{"key":"10.1016\/j.bmc.2024.117752_b0030","unstructured":"Polycomb silencers control cell fate, development and cancer - PubMed, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/17060944\/ (accessed June 8, 2023)."},{"key":"10.1016\/j.bmc.2024.117752_b0035","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1471-2164-15-S1-S7","article-title":"A nucleosomal approach to inferring causal relationships of histone modifications","volume":"15","author":"Le","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bmc.2024.117752_b0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrd4286","article-title":"Targeting bromodomains: epigenetic readers of lysine acetylation","volume":"13","author":"Filippakopoulos","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2024.117752_b0045","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.18632\/oncotarget.3551","article-title":"Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery","volume":"6","author":"Fu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmc.2024.117752_b0050","first-page":"17","article-title":"Histone acetylation and chromatin pattern in cancer. A review","volume":"29","author":"Orr","year":"2007","journal-title":"Anal Quant Cytol Histol"},{"key":"10.1016\/j.bmc.2024.117752_b0055","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1021\/acs.jmedchem.0c01487","article-title":"Targeting bromodomain and extraterminal proteins for drug discovery: from current progress to technological development","volume":"64","author":"Tang","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117752_b0060","doi-asserted-by":"crossref","first-page":"11962","DOI":"10.1038\/s41598-017-12342-2","article-title":"BRD4 regulates adiponectin gene induction by recruiting the P-TEFb complex to the transcribed region of the gene","volume":"7","author":"Sakurai","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2024.117752_b0065","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1021\/acschembio.5b00831","article-title":"The Bromodomain: A New Target in Emerging Epigenetic Medicine","volume":"11","author":"Smith","year":"2016","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmc.2024.117752_b0070","doi-asserted-by":"crossref","first-page":"13141","DOI":"10.1074\/jbc.R700001200","article-title":"The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation","volume":"282","author":"Wu","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.117752_b0075","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cell.2012.02.013","article-title":"Histone recognition and large-scale structural analysis of the human bromodomain family","volume":"149","author":"Filippakopoulos","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2024.117752_b0080","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ccr.2014.01.028","article-title":"Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer","volume":"25","author":"Shi","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bmc.2024.117752_b0085","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2024.117752_b0090","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1158\/1078-0432.CCR-14-1561","article-title":"The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs","volume":"21","author":"Boi","year":"2015","journal-title":"Clin. Cancer Res. off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.bmc.2024.117752_b0095","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1016\/j.bmcl.2012.02.041","article-title":"Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A)","volume":"22","author":"Seal","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117752_b0100","doi-asserted-by":"crossref","first-page":"8369","DOI":"10.1021\/acs.jmedchem.7b00746","article-title":"Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075\/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor","volume":"60","author":"McDaniel","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117752_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107479","article-title":"Make your best BET: The emerging role of BET inhibitor treatment in malignant tumors","volume":"208","author":"Bechter","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmc.2024.117752_b0110","doi-asserted-by":"crossref","first-page":"11080","DOI":"10.1021\/acs.jmedchem.9b01010","article-title":"Discovery of Benzo[cd]indol-2(1H)-ones and Pyrrolo[4,3,2-de]quinolin-2(1H)-ones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain with Potential High Efficiency against Acute Gouty Arthritis","volume":"62","author":"Jiang","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117752_b0115","doi-asserted-by":"crossref","first-page":"9020","DOI":"10.1021\/acs.jmedchem.0c00566","article-title":"Structure-Based Design of a Bromodomain and Extraterminal Domain (BET) Inhibitor Selective for the N-Terminal Bromodomains That Retains an Anti-inflammatory and Antiproliferative Phenotype","volume":"63","author":"Wellaway","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117752_b0120","doi-asserted-by":"crossref","first-page":"19754","DOI":"10.1073\/pnas.1310658110","article-title":"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain","volume":"110","author":"Picaud","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2024.117752_b0125","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41586-020-1930-8","article-title":"Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer","volume":"578","author":"Faivre","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2024.117752_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112780","article-title":"Design, synthesis and biological evaluation of indole-2-one derivatives as potent BRD4 inhibitors","volume":"208","author":"Xu","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117752_b0135","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1177\/1087057109339207","article-title":"Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform","volume":"14","author":"Lebakken","year":"2009","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.bmc.2024.117752_b0140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-61779-080-5_20","article-title":"Cell sensitivity assays: the MTT assay","volume":"731","author":"van Meerloo","year":"2011","journal-title":"Methods Mol. Biol. Clifton NJ."},{"key":"10.1016\/j.bmc.2024.117752_b0145","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/ncb2097","article-title":"Coordinate control of gene expression noise and interchromosomal interactions in a MAP kinase pathway","volume":"12","author":"McCullagh","year":"2010","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.bmc.2024.117752_b0150","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/qua.24481","article-title":"Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences","volume":"113","author":"Bochevarov","year":"2013","journal-title":"Int J Quantum Chem"},{"key":"10.1016\/j.bmc.2024.117752_b0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10822-010-9395-8","article-title":"Computer-aided drug design platform using PyMOL","volume":"25","author":"Lill","year":"2011","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.bmc.2024.117752_b0160","doi-asserted-by":"crossref","first-page":"16669","DOI":"10.1073\/pnas.1108190108","article-title":"Targeting MYC dependence in cancer by inhibiting BET bromodomains","volume":"108","author":"Mertz","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2024.117752_b0165","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejmech.2019.06.067","article-title":"Novel phenanthridin-6(5H)-one derivatives as potent and selective BET bromodomain inhibitors: Rational design, synthesis and biological evaluation","volume":"179","author":"Zhi","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117752_b0170","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1074\/jbc.M111.282855","article-title":"Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes","volume":"287","author":"Schr\u00f6der","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.117752_b0175","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/MCB.20.17.6537-6549.2000","article-title":"A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition","volume":"20","author":"Dey","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bmc.2024.117752_b0180","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1091\/mbc.e09-05-0380","article-title":"Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription","volume":"20","author":"Dey","year":"2009","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.bmc.2024.117752_b0185","first-page":"2597","article-title":"Modified annexin V\/propidium iodide apoptosis assay for accurate assessment of cell death","author":"Rieger","year":"2011","journal-title":"J. vis. Exp. Jove."}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624001664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624001664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T12:06:55Z","timestamp":1716120415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624001664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":37,"alternative-id":["S0968089624001664"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117752","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of indole-2-one derivatives as BRD4 (BD1) selective inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117752"}}